Oncomatryx Biopharma S.l.
Clinical trials sponsored by Oncomatryx Biopharma S.l., explained in plain language.
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called OMTX705, alone or with an immunotherapy, in adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the best dose. About 150 participants will join this study across…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
New hope for pancreatic cancer: targeted drug combo enters human trials
Disease control Recruiting nowThis early-phase trial tests a new drug, OMTX705, that targets a protein found on cancer-supporting cells. It is given together with standard chemotherapy and an immunotherapy drug for people with advanced or metastatic pancreatic cancer. The study aims to find the safest dose an…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC